Conflict of interest: No authors have relevant conflicts of interest to declare with the exception of Dr. Price who reports receipt of consulting honoraria from Boston Scientific, W.L. Gore, and St. Jude; honoraria for proctoring from SentreHeart and W.L. Gore, and research support (to institution) from SentreHeart.
Valvular and Structural Heart Diseases
Percutaneous management of late leak after lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke
Version of Record online: 9 NOV 2013
Copyright © 2013 Wiley Periodicals, Inc.
Catheterization and Cardiovascular Interventions
Volume 83, Issue 4, pages 664–669, 1 March 2014
How to Cite
Mosley, W. J., Smith, M. R. and Price, M. J. (2014), Percutaneous management of late leak after lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke. Cathet. Cardiovasc. Intervent., 83: 664–669. doi: 10.1002/ccd.25251
- Issue online: 15 FEB 2014
- Version of Record online: 9 NOV 2013
- Accepted manuscript online: 15 OCT 2013 12:08PM EST
- Manuscript Accepted: 10 OCT 2013
- Manuscript Revised: 25 SEP 2013
- Manuscript Received: 19 JUN 2013
- left atrial appendage;
- atrial fibrillation;
- left atrial appendage occlusion;
Left atrial appendage (LAA) occlusion or ligation is a novel approach to stroke prevention in atrial fibrillation that may obviate the need for long-term anticoagulation. The Lariat device has received Food and Drug Administration 510K clearance for the approximation of soft tissue and has been applied to transcatheter LAA ligation using a combined trans-pericardial and transseptal approach. The occurrence of late leak after transcatheter LAA ligation and its percutaneous management has not been previously reported. Herein, we report three cases of late leak with reconstitution of the LAA after initially successful Lariat closure, and present a simple percutaneous technique for leak closure. © 2013 Wiley Periodicals, Inc.